Test Directory
| Test Code | |||
| PAI1P | |||
| Test Name | |||
| PAI-1 Gene Polymorphism | |||
| CPT Codes | |||
| 81400 | |||
| Expected Turnaround Time | |||
| 7 - 11 days | |||
| Clinical Utility | |||
|
Plasma plasminogen activator inhibitor, PAI-1 is a major inhibitor of fibrinolysis. The 4G variant (AF386492.2:g.837del) in the PAI-1 (Serpine 1) gene promoter region is associated with an increase in the level of PAI-1 in plasma. Increased levels of PAI-1 in plasma may increase the risk for arterial and venous thrombosis, myocardial infarction, and progression of atherosclerosis and also recurrent spontaneous abortion. |
|||
| Specimen and Container Info | |||
|
Specimen Type: Whole Blood
Collection Container: Yellow Top (ACD solution A or B) Alternate Collection Container: Green Top (sodium or lithium heparin) or Lavender Top (EDTA)
Desired Specimen Volume: 5 mL |
|||
| Collection Instructions | |||
|
|||
| Processing and Submission Instructions | |||
|
|||
| Transport Instructions | |||
|
Transport to the laboratory at room temperature. |
|||
| Stability Requirements | |||
|
|||
| Methodology | |||
| Polymerase Chain Reaction (PCR) | |||
| Reference Intervals | |||
|
See patient report. |
|||
| Alternate Names | |||
|
|||
| Reference Lab | |||
| Quest Diagnostics Nichols Institute | |||
| Testing Schedule | |||
| Routine, 2 times per week | |||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.